These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37851084)
1. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia. Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084 [TBL] [Abstract][Full Text] [Related]
2. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity. Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795 [TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma. Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569 [TBL] [Abstract][Full Text] [Related]
4. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia. Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251 [TBL] [Abstract][Full Text] [Related]
5. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia. Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799 [TBL] [Abstract][Full Text] [Related]
6. Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia. Yazıcıoğlu B; Kaya Z; Güntekin Ergun S; Perçin F; Koçak Ü; Yenicesu İ; Gürsel T Turk J Haematol; 2017 Jun; 34(2):143-150. PubMed ID: 27094381 [TBL] [Abstract][Full Text] [Related]
7. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia]. Zheng MM; Yue LJ; Chen XW; Wen FQ; Li CG; Yang CL; Xie C; Ding H Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762 [TBL] [Abstract][Full Text] [Related]
9. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy]. Liao QC; Li XL; Liu ST; Zhang Y; Li TY; Qiu JC Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):735-9. PubMed ID: 22968027 [TBL] [Abstract][Full Text] [Related]
10. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia. El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011 [TBL] [Abstract][Full Text] [Related]
11. [Effect of GSTP1 and MTHFR Gene Polymorphism on Side Effects of HD-MTX in ALL Children]. Li F; Yin DD; Zhou XL; Ma JM; Guo HM; Meng L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):723-728. PubMed ID: 28641625 [TBL] [Abstract][Full Text] [Related]
12. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia. Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438 [TBL] [Abstract][Full Text] [Related]
13. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population. Liu SG; Li ZG; Cui L; Gao C; Li WJ; Zhao XX Leuk Lymphoma; 2011 Jun; 52(6):1030-40. PubMed ID: 21534867 [TBL] [Abstract][Full Text] [Related]
14. Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia. Chae H; Kim M; Choi SH; Kim SK; Lee JW; Chung NG; Cho B; Kim Y J Chemother; 2020 Sep; 32(5):251-259. PubMed ID: 32431230 [TBL] [Abstract][Full Text] [Related]
15. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer. Hagleitner MM; Coenen MJ; Aplenc R; Patiño-Garcia A; Chiusolo P; Gemmati D; De Mattei M; Ongaro A; Krajinovic M; Hoogerbrugge PM; Vermeulen SH; te Loo DM Pharmacogenomics J; 2014 Apr; 14(2):115-9. PubMed ID: 23648444 [TBL] [Abstract][Full Text] [Related]
16. High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination. Ebid AIM; Hossam A; El Gammal MM; Soror S; Mangoud NOM; Mahmoud MA J Chemother; 2022 Oct; 34(6):381-390. PubMed ID: 34895107 [TBL] [Abstract][Full Text] [Related]
17. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. Schmeling H; Biber D; Heins S; Horneff G J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884 [TBL] [Abstract][Full Text] [Related]
18. Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia. Wang SM; Zeng WX; Wu WS; Sun LL; Yan D J Gene Med; 2017 Nov; 19(11):353-359. PubMed ID: 28990296 [TBL] [Abstract][Full Text] [Related]
19. Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate. Choi YJ; Park H; Lee JS; Lee JY; Kim S; Kim TW; Park JS; Kim JE; Yoon DH; Suh C Hematol Oncol; 2017 Dec; 35(4):504-509. PubMed ID: 27781293 [TBL] [Abstract][Full Text] [Related]
20. Association of Karschnia P; Kurz SC; Brastianos PK; Winter SF; Gordon A; Jones S; Pisapia M; Nayyar N; Tonn JC; Batchelor TT; Plotkin SR; Dietrich J Neurology; 2023 Oct; 101(17):e1741-e1746. PubMed ID: 37527941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]